AEGiS-AP: A glance at AIDS drug nevirapine Associated PressImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu




DonateNow



A glance at AIDS drug nevirapine

Associated Press - December 13, 2004


THE DRUG: Nevirapine, an AIDS drug pronounced Nee-VERA-peen, is made by Boehringer Ingelheim Corp. and is marketed under the brand name Viramune. There are two generic versions, Nevimune, made by Cipla, and Nevirex, made by Aurobindo Pharma.

HOW IT WORKS: Nevirapine, a non-nucleoside reverse transcriptase inhibitor, blocks an HIV protein that the virus uses to make new viral particles.

HOW IT IS USED: Nevirapine is generally taken once or twice a day in combination with other anti-AIDS drugs, such as AZT or didanosine.

EXPERIMENTAL USE: Nevirapine was tested in Uganda, Kenya and Thailand to see if a single dose to a mother in labor and one later to the newborn could prevent HIV transmission from an infected, pregnant woman to her baby.

RESISTANCE PROBLEMS: Studies found that birthing mothers who received nevirapine could develop an HIV virus resistant to some HIV drugs, including nevirapine. This could make their later AIDS treatment less effective.

SIDE EFFECTS: Liver toxicity occurs in some patients. About 16 percent of patients develop a skin rash. Other common side effects include nausea, fatigue, headache, vomiting, diarrhea and abdominal and muscle pain.


041213
AP041239


Copyright © 2004 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .